Table 1.
Diagnosis type | Case (n) | MCM2 expression level | Detection of “High-risk” HPV type | ||||||
---|---|---|---|---|---|---|---|---|---|
|
|
||||||||
- | + | ++ | +++ | Positive rate (%) | - | + | Positive rate (%) | ||
Cytology | |||||||||
SCC | 9 | 0 | 1 | 1 | 7 | 100a | 0 | 9 | 100a |
HSIL | 39 | 2 | 6 | 6 | 25 | 94.87a | 4 | 35 | 89.74a |
SIl | 45 | 6 | 12 | 9 | 18 | 86.67a | 2 | 43 | 95.5a |
ASCUS | 83 | 37 | 29 | 9 | 8 | 55.42b | 36 | 47 | 56.63b |
NILM | 7 | 5 | 2 | 0 | 0 | 28.57b | 7 | 0 | 0c |
Histology | |||||||||
SCC | 37 | 1 | 3 | 4 | 29 | 97.30a | 4 | 33 | 89.19ab |
CIN III | 38 | 1 | 9 | 11 | 17 | 97.37a | 1 | 37 | 97.37a |
CIN II | 22 | 4 | 6 | 7 | 5 | 81.82b | 6 | 16 | 72.73bc |
CIN I | 29 | 12 | 15 | 0 | 2 | 58.62bc | 9 | 20 | 68.97c |
Chronic Inflammation | 57 | 32 | 17 | 3 | 5 | 43.86c | 29 | 28 | 49.12c |
Note: Positive rate (%) followed by the same footnote symbol(s) for each group are not significantly different at P < 0.05.